Business Insights

In this episode, Atlas Air’s Richard Broekman and Katherine Preston join our expert Nikhil Sachdeva to discuss how the air cargo industry is moving forward with decarbonization, even amid geopolitical and market disruptions.

The conversation covers Atlas Air’s targets, its investments in sustainable aviation fuel, fleet modernization, and operational efficiency. As the sector faces both regulatory complexity and supply chain volatility, the focus is shifting from long-term ambition to actionable progress. What role will air cargo play in enabling greener global trade?

For more information, visit our website at rolandberger.com.

In this episode on the future of healthcare, our partner Thilo Kaltenbach speaks with Prof. Dr. med. Harald HHW Schmidt about the rise of network pharmacology and its potential to transform pharmaceutical research and development. The conversation explores how moving beyond organ-based definitions of disease could enable a step change in treating root causes rather than symptoms.
What will this mean for pharma business models, clinical pathways, and the health systems of tomorrow?
For more information, visit our website at rolandberger.com.

In this episode, our partners Thilo Kaltenbach and Karsten Neumann explore the rapidly evolving landscape of AI in healthcare. It is pretty clear that AI is transforming our lives and all industries. However, how does it play out in the highly regulated healthcare market? Is it more revolution or evolution? From early diagnosis to personalized medicine, AI-powered hospitals and workforce changes, the topic highlights the tangible impacts of AI on patients, physicians, and organizations. With executives aware of AI's potential but facing readiness gaps, key strategic moves need to be executed to stay ahead in this fast-moving field.
For more...

In this episode, biologist, TV anchor, and staYoung founder Nina Ruge joins our partner Thilo Kaltenbach to explore the increasing focus on life expectancy and health span. Both have risen significantly over the past century, and new medicines and nutritional supplements are now shaping the next phase of the market for healthy aging.
As aging affects everyone, the longevity sector is creating new opportunities for pharma companies, healthcare providers, and investors. With the market expected to double to $60 billion by 2033, early investments in innovation could deliver strong returns.
For more information, visit our website at rolandberger.com.